Belpointe Asset Management LLC grew its stake in Opko Health Inc. (NASDAQ:OPK) by 30.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 110,500 shares of the biotechnology company’s stock after buying an additional 25,500 shares during the quarter. Belpointe Asset Management LLC’s holdings in Opko Health were worth $541,000 as of its most recent SEC filing.
Several other hedge funds also recently modified their holdings of OPK. Dimensional Fund Advisors LP lifted its holdings in shares of Opko Health by 127.2% in the 3rd quarter. Dimensional Fund Advisors LP now owns 4,003,643 shares of the biotechnology company’s stock valued at $27,466,000 after buying an additional 2,241,103 shares during the period. Cornerstone Capital Management Holdings LLC. increased its stake in shares of Opko Health by 611.8% in the 3rd quarter. Cornerstone Capital Management Holdings LLC. now owns 1,445,310 shares of the biotechnology company’s stock valued at $9,913,000 after purchasing an additional 1,242,272 shares in the last quarter. Guggenheim Capital LLC increased its stake in shares of Opko Health by 800.4% in the 4th quarter. Guggenheim Capital LLC now owns 605,609 shares of the biotechnology company’s stock valued at $2,967,000 after purchasing an additional 538,349 shares in the last quarter. IFP Advisors Inc increased its stake in shares of Opko Health by 37.1% in the 4th quarter. IFP Advisors Inc now owns 1,963,601 shares of the biotechnology company’s stock valued at $9,622,000 after purchasing an additional 531,088 shares in the last quarter. Finally, X Square Capital LLC purchased a new position in shares of Opko Health in the 4th quarter valued at about $2,363,000. 23.40% of the stock is owned by institutional investors and hedge funds.
In other news, CEO Phillip Md Et Al Frost acquired 100,000 shares of the business’s stock in a transaction on Monday, January 22nd. The stock was bought at an average cost of $4.40 per share, for a total transaction of $440,000.00. Following the purchase, the chief executive officer now owns 3,068,951 shares in the company, valued at $13,503,384.40. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In the last 90 days, insiders purchased 1,394,365 shares of company stock valued at $5,231,738. 40.19% of the stock is owned by company insiders.
Opko Health Inc. (NASDAQ:OPK) opened at $3.60 on Friday. The company has a quick ratio of 0.98, a current ratio of 1.14 and a debt-to-equity ratio of 0.02. Opko Health Inc. has a 52 week low of $2.66 and a 52 week high of $8.51. The firm has a market capitalization of $1,874.24, a PE ratio of -6.43 and a beta of 1.60.
OPK has been the subject of several recent analyst reports. Cantor Fitzgerald set a $20.00 price target on Opko Health and gave the company a “buy” rating in a research note on Thursday, March 1st. Zacks Investment Research upgraded Opko Health from a “sell” rating to a “hold” rating in a research note on Tuesday, December 12th. BidaskClub upgraded Opko Health from a “strong sell” rating to a “sell” rating in a research note on Friday, January 26th. ValuEngine lowered Opko Health from a “sell” rating to a “strong sell” rating in a research note on Thursday, March 1st. Finally, JPMorgan Chase & Co. lowered Opko Health from a “neutral” rating to an “underweight” rating and set a $7.00 price target for the company. in a research note on Friday, March 2nd. Four equities research analysts have rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company’s stock. Opko Health has an average rating of “Hold” and a consensus price target of $11.29.
WARNING: This article was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this article on another website, it was copied illegally and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://ledgergazette.com/2018/03/17/belpointe-asset-management-llc-has-541000-stake-in-opko-health-inc-opk.html.
Opko Health Company Profile
OPKO Health, Inc is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations.
Want to see what other hedge funds are holding OPK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Opko Health Inc. (NASDAQ:OPK).
Receive News & Ratings for Opko Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health and related companies with MarketBeat.com's FREE daily email newsletter.